MS

Milind Shashikant Ponkshe

Director DIN 06570450
DIN 06570450 First appointment Jun 2013
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Milind Shashikant Ponkshe

Data last updated:

Milind Shashikant Ponkshe was a Director at Zap Remedies Private Limited (from 2015) and Director at Amity Remedies Private Limited (from 2013).

DIN 06570450
First Appointment 14 Jun 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zap Remedies Private Limited U85191MH2015PTC263009
Director26 Mar 20152015₹7.9 Lakh (FY 2016)Strike Off
Amity Remedies Private Limited U85190MH2013PTC244495
Director14 Jun 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Zap Remedies Private Limited
Amity Remedies Private Limited
Premium access

Shareholding and investment profile for Milind Shashikant Ponkshe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Milind Shashikant Ponkshe

Milind Shashikant Ponkshe was first appointed on 14 Jun 2013 as Director at Amity Remedies Private Limited. The most recent appointment on record is 26 Mar 2015 at Zap Remedies Private Limited.

Milind Shashikant Ponkshe held 2 earlier board appointments: Zap Remedies Private Limited (Director, from 26 Mar 2015); Amity Remedies Private Limited (Director, from 14 Jun 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available